Sfoglia per Autore
Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinoma
2012-01-01 Nersita, Roberto; Matrone, Antonio; Klain, Michele; Scavuzzo, Francesco; Vitolo, Gabriella; Abbondanza, Ciro; Carlino, Maria V.; Giacco, Veronica; Amato, Giovanni; Carella, Carlo
AFTER 20 YEARS, RET GENETIC SCREENING STILL INDENTIFIES NEW GERMILINE AND SOMATIC MUTATIONS
2013-01-01 Tacito, Alessia; Romei, Cristina; Vivaldi, Agnese; Ciampi, Raffaele; Matrone, Antonio; Bottici, Valeria; Cappagli, Virginia; Elisei, Rossella
GENETIC SCREENING OF RET CAN IDENTIFY NEW MUTATIONS EVEN AFTER 20 YEARS
2013-01-01 Romei, Cristina; Tacito, Alessia; Vivaldi, Agnese; Ciampi, Raffaele; Matrone, Antonio; Bottici, Valeria; Cappagli, Virginia; Elisei, Rossella
After 20 Years, RET genetic screening still identifies new germline and somatic mutations
2013-01-01 Tacito, A; Romei, C; Vivaldi, A; Ciampi, R; Matrone, A; Bottici, V; Cappagli, V; Elisei, R
Recombinant Human Thyrotropin Stimulation Thyroglobulin (rhTSH-Tg) test can identify false serum tg due to heterophilic antibodies in differentiated thyroid cancer (DTC) patients
2013-01-01 Matrone, A; Gambale, C; Taddei, D; Nencetti, C; Molinaro, E; Agate, L; Bottici, V; Viola, D; Vitti, P; Elisei, R
Il carcinoma tiroideo: nuove prospettive terapeutiche.
2014-01-01 Viola, David; Agate, Laura; Molinaro, Eleonora; Bottici, Valeria; Lorusso, Loredana; Valerio, Laura; Matrone, Antonio; Biagini, Agnese; Cappagli, Virginia; Giani, Carlotta; Pieruzzi, Letizia; Contillo, Benedetta Pontillo; Battaglia, Valentina; Mazzeo, Salvatore; Elisei, Rossella
CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE
2014-01-01 Casella, F.; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina
The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC)
2014-01-01 Gambale, Carla; Matrone, Antonio; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Biagini, Agnese; Viola, David; Mazzeo, Salvatore; Bianchi, Francesca; Brozzi, Federica; Vitti, Paolo; Elisei, Rossella
Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC)
2014-01-01 Matrone, A.; Gambale, C.; Molinaro, E.; Agate, L.; Bottici, V.; Biagini, A.; Viola, D.; Vitti, P.; Elisei, R.
How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level.
2014-01-01 Elisei, Rossella; Agate, Laura; Viola, David; Matrone, A; Biagini, Agnese; Molinaro, Eleonora
Clinical Impact Of Ret Genetic Screening Of In The Management Of Medullary Thyroid Carcinoma (MTC) Patients: 20 Years Of Experience
2014-01-01 Casella, Francesca; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina
Ret Oncogene and Thyroid Carcinoma
2014-01-01 Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Biagini, Agnese; Matrone, Antonio; Tacito, Alessia; Ciampi, Raffaele; Vivaldi, Agnese; Romei, Cristina
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
2015-01-01 Romei, Cristina; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Matrone, Antonio; Biagini, Agnese; Casella, Francesca; Ciampi, Raffaele; Materazzi, Gabriele; Miccoli, Paolo; Torregrossa, Liborio; Ugolini, Clara; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella
5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I
2015-01-01 Matrone, A.; Faranda, A.; Molinaro, E.; Agate, L.; Viola, D.; Valerio, L.; Giani, C.; Torregrossa, L.; Piaggi, P.; Vitti, P.; Elisei, R.
A novel fusion RET/PTC3 involving NCOA4 and RET genes in a pediatric case of Papillary Thyroid Carcinoma
2015-01-01 Ciampi, Raffaele; Romei, Cristina; Tacito, Alessia; Casella, Francesca; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Vitti, Paolo; Elisei, Rossella
Cabozantinib: An orphan drug for thyroid cancer
2015-01-01 Viola, D.; Cappagli, V.; Matrone, A.; Mazzeo, S.; Elisei, R.
The Mutation Profile Of Medullary Thyroid Carcinoma Can Be Different In Primary And Metastatic Tissues
2016-01-01 Romei, Cristina; Casella, Francesca; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Elisei, Rossella
A Patient with Advanced Medullary Thyroid Cancer and Progressive Symptomatic Distant Metastases: When to Start Systemic Therapy
2016-01-01 Giani, Carlotta; Matrone, Antonio; Elisei, Rossella
Correlation Between The Presence Of Macrophages And Braf V600e Mutation In Different Variants Of Well Differentiated Papillary Thyroid Cancer
2016-01-01 Puleo, Luciana; Ugolini, Clara; Viola, David; Molinaro, Eleonora; Agate, Laura; Matrone, Antonio; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella; Romei, Cristina
La scintigrafia con 99mTecnezio-metossi-isobutil-isonitrile è una metodica utile per caratterizzare il rischio di malignità nei noduli tiroidei a citologia indeterminata
2016-01-01 Matrone, Antonio; Elisei, Rossella
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Decreased serum vascular endothelial growth factor-D levels in metastatic patients with differentiated thyroid carcinoma | 1-gen-2012 | Nersita, Roberto; Matrone, Antonio; Klain, Michele; Scavuzzo, Francesco; Vitolo, Gabriella; Abbondanza, Ciro; Carlino, Maria V.; Giacco, Veronica; Amato, Giovanni; Carella, Carlo | |
| AFTER 20 YEARS, RET GENETIC SCREENING STILL INDENTIFIES NEW GERMILINE AND SOMATIC MUTATIONS | 1-gen-2013 | Tacito, Alessia; Romei, Cristina; Vivaldi, Agnese; Ciampi, Raffaele; Matrone, Antonio; Bottici, Valeria; Cappagli, Virginia; Elisei, Rossella | |
| GENETIC SCREENING OF RET CAN IDENTIFY NEW MUTATIONS EVEN AFTER 20 YEARS | 1-gen-2013 | Romei, Cristina; Tacito, Alessia; Vivaldi, Agnese; Ciampi, Raffaele; Matrone, Antonio; Bottici, Valeria; Cappagli, Virginia; Elisei, Rossella | |
| After 20 Years, RET genetic screening still identifies new germline and somatic mutations | 1-gen-2013 | Tacito, A; Romei, C; Vivaldi, A; Ciampi, R; Matrone, A; Bottici, V; Cappagli, V; Elisei, R | |
| Recombinant Human Thyrotropin Stimulation Thyroglobulin (rhTSH-Tg) test can identify false serum tg due to heterophilic antibodies in differentiated thyroid cancer (DTC) patients | 1-gen-2013 | Matrone, A; Gambale, C; Taddei, D; Nencetti, C; Molinaro, E; Agate, L; Bottici, V; Viola, D; Vitti, P; Elisei, R | |
| Il carcinoma tiroideo: nuove prospettive terapeutiche. | 1-gen-2014 | Viola, David; Agate, Laura; Molinaro, Eleonora; Bottici, Valeria; Lorusso, Loredana; Valerio, Laura; Matrone, Antonio; Biagini, Agnese; Cappagli, Virginia; Giani, Carlotta; Pieruzzi, Letizia; Contillo, Benedetta Pontillo; Battaglia, Valentina; Mazzeo, Salvatore; Elisei, Rossella | |
| CLINICAL IMPACT OF RET GENETIC SCREENING IN THE MANAGEMENT OF MEDULLARY THYROID CARCINOMA (MTC) PATIENTS: 20 YEARS OF EXPERIENCE | 1-gen-2014 | Casella, F.; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina | |
| The Thymic Hyperplasia (TH) And Biochemical Persistence Of Disease In Patients With Differentiated Thyroid Carcinoma (DTC) | 1-gen-2014 | Gambale, Carla; Matrone, Antonio; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Biagini, Agnese; Viola, David; Mazzeo, Salvatore; Bianchi, Francesca; Brozzi, Federica; Vitti, Paolo; Elisei, Rossella | |
| Predictive Value Of High Sensitive Thyroglobulin Assay (USTG) And Neck Ultrasonography (US) At The Time Of Remnant Ablation On Lt-4 Therapy In Patients With Low And Intermediate Risk Differentiated Thyroid Cancer (DTC) | 1-gen-2014 | Matrone, A.; Gambale, C.; Molinaro, E.; Agate, L.; Bottici, V.; Biagini, A.; Viola, D.; Vitti, P.; Elisei, R. | |
| How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level. | 1-gen-2014 | Elisei, Rossella; Agate, Laura; Viola, David; Matrone, A; Biagini, Agnese; Molinaro, Eleonora | |
| Clinical Impact Of Ret Genetic Screening Of In The Management Of Medullary Thyroid Carcinoma (MTC) Patients: 20 Years Of Experience | 1-gen-2014 | Casella, Francesca; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Biagini, Agnese; Elisei, Rossella; Romei, Cristina | |
| Ret Oncogene and Thyroid Carcinoma | 1-gen-2014 | Elisei, Rossella; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Biagini, Agnese; Matrone, Antonio; Tacito, Alessia; Ciampi, Raffaele; Vivaldi, Agnese; Romei, Cristina | |
| Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? | 1-gen-2015 | Romei, Cristina; Tacito, Alessia; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Viola, David; Matrone, Antonio; Biagini, Agnese; Casella, Francesca; Ciampi, Raffaele; Materazzi, Gabriele; Miccoli, Paolo; Torregrossa, Liborio; Ugolini, Clara; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella | |
| 5 YEARS FOLLOW UP OF THYROGLOBULIN (TG), THYROGLOBULIN ANTIBODIES (TGAB) AND NECK ULTRASOUND (US) IN PATIENTS WITH PAPILLARY THYROID MICROCARCINOMA (MPTC) TREATED WITH TOTAL THYROIDECTOMY BUT NOT ABLATED WITH 131I | 1-gen-2015 | Matrone, A.; Faranda, A.; Molinaro, E.; Agate, L.; Viola, D.; Valerio, L.; Giani, C.; Torregrossa, L.; Piaggi, P.; Vitti, P.; Elisei, R. | |
| A novel fusion RET/PTC3 involving NCOA4 and RET genes in a pediatric case of Papillary Thyroid Carcinoma | 1-gen-2015 | Ciampi, Raffaele; Romei, Cristina; Tacito, Alessia; Casella, Francesca; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Vitti, Paolo; Elisei, Rossella | |
| Cabozantinib: An orphan drug for thyroid cancer | 1-gen-2015 | Viola, D.; Cappagli, V.; Matrone, A.; Mazzeo, S.; Elisei, R. | |
| The Mutation Profile Of Medullary Thyroid Carcinoma Can Be Different In Primary And Metastatic Tissues | 1-gen-2016 | Romei, Cristina; Casella, Francesca; Tacito, Alessia; Ciampi, Raffaele; Molinaro, Eleonora; Agate, Laura; Bottici, Valeria; Matrone, Antonio; Elisei, Rossella | |
| A Patient with Advanced Medullary Thyroid Cancer and Progressive Symptomatic Distant Metastases: When to Start Systemic Therapy | 1-gen-2016 | Giani, Carlotta; Matrone, Antonio; Elisei, Rossella | |
| Correlation Between The Presence Of Macrophages And Braf V600e Mutation In Different Variants Of Well Differentiated Papillary Thyroid Cancer | 1-gen-2016 | Puleo, Luciana; Ugolini, Clara; Viola, David; Molinaro, Eleonora; Agate, Laura; Matrone, Antonio; Basolo, Fulvio; Vitti, Paolo; Elisei, Rossella; Romei, Cristina | |
| La scintigrafia con 99mTecnezio-metossi-isobutil-isonitrile è una metodica utile per caratterizzare il rischio di malignità nei noduli tiroidei a citologia indeterminata | 1-gen-2016 | Matrone, Antonio; Elisei, Rossella |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile